Clinical Trial

A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients with PV
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2022-07-28; most recent amendment 2025-08-08.
Status change: Recruiting → Active, Not Recruiting 2024-10-21
Status change: Active, Not Recruiting → Recruiting 2023-03-23
Status change: Not Yet Recruiting → Active, Not Recruiting 2022-11-09
Trial Details
NCT Number NCT05481151
Lead Sponsor PharmaEssentia
Conditions Polycythemia Vera
Enrollment 111 participants
Start Date 2022-10-26
Primary Completion 2025-06-30 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-13